142 related articles for article (PubMed ID: 38394289)
21. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
Armstrong EP
J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
[TBL] [Abstract][Full Text] [Related]
22. Use of community forums to increase knowledge of HPV and cervical cancer in African American communities.
Teteh DK; Dawkins-Moultin L; Robinson C; LaGroon V; Hooker S; Alexander K; Kittles RA
J Community Health; 2019 Jun; 44(3):492-499. PubMed ID: 30989454
[TBL] [Abstract][Full Text] [Related]
23. HPV Testing Behaviors and Willingness to Use HPV Self-sampling at Home Among African American (AA) and Sub-Saharan African Immigrant (SAI) Women.
Adegboyega A; Wiggins AT; Williams LB; Dignan M
J Racial Ethn Health Disparities; 2022 Dec; 9(6):2485-2494. PubMed ID: 34780021
[TBL] [Abstract][Full Text] [Related]
24. Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women.
Joseph NP; Clark JA; Bauchner H; Walsh JP; Mercilus G; Figaro J; Bibbo C; Perkins RB
Womens Health Issues; 2012; 22(6):e571-9. PubMed ID: 23122214
[TBL] [Abstract][Full Text] [Related]
25. Education, income and occupation and their influence on the uptake of cervical cancer prevention strategies: A systematic review.
Murfin J; Irvine F; Meechan-Rogers R; Swift A
J Clin Nurs; 2020 Feb; 29(3-4):393-415. PubMed ID: 31713934
[TBL] [Abstract][Full Text] [Related]
26. Concept mapping sociocultural aspects of cervical cancer prevention among African American women.
Carmack C; Roncancio A; Coleman TM; McKay S
Front Public Health; 2023; 11():1311286. PubMed ID: 38370530
[TBL] [Abstract][Full Text] [Related]
27. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial.
Scarinci IC; Li Y; Tucker L; Campos NG; Kim JJ; Peral S; Castle PE
Prev Med; 2021 Jan; 142():106358. PubMed ID: 33338505
[TBL] [Abstract][Full Text] [Related]
28. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
[TBL] [Abstract][Full Text] [Related]
29. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
Praditsitthikorn N; Teerawattananon Y; Tantivess S; Limwattananon S; Riewpaiboon A; Chichareon S; Ieumwananonthachai N; Tangcharoensathien V
Pharmacoeconomics; 2011 Sep; 29(9):781-806. PubMed ID: 21838332
[TBL] [Abstract][Full Text] [Related]
30. An extended cost-effectiveness analysis of publicly financed HPV vaccination to prevent cervical cancer in China.
Levin CE; Sharma M; Olson Z; Verguet S; Shi JF; Wang SM; Qiao YL; Jamison DT; Kim JJ
Vaccine; 2015 Jun; 33(24):2830-41. PubMed ID: 25770785
[TBL] [Abstract][Full Text] [Related]
31. Prevention of Cervical Cancer in Low-Resource African Settings.
Mulongo M; Chibwesha CJ
Obstet Gynecol Clin North Am; 2022 Dec; 49(4):771-781. PubMed ID: 36328679
[TBL] [Abstract][Full Text] [Related]
32. Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program.
Demarteau N; Breuer T; Standaert B
Pharmacoeconomics; 2012 Apr; 30(4):337-53. PubMed ID: 22409292
[TBL] [Abstract][Full Text] [Related]
33. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
34. Assessing HPV and Cervical Knowledge, Preference and HPV Status Among Urban American Indian Women.
Cina KR; Omidpanah AA; Petereit DG
S D Med; 2017 Oct; 70(10):439-443. PubMed ID: 28957617
[TBL] [Abstract][Full Text] [Related]
35. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
[TBL] [Abstract][Full Text] [Related]
36. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract][Full Text] [Related]
37. Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology.
Zehbe I; Jackson R; Wood B; Weaver B; Escott N; Severini A; Krajden M; Bishop L; Morrisseau K; Ogilvie G; Burchell AN; Little J
BMJ Open; 2016 Oct; 6(10):e011754. PubMed ID: 27855089
[TBL] [Abstract][Full Text] [Related]
38. Racial Disparities in HPV-related Knowledge, Attitudes, and Beliefs Among African American and White Women in the USA.
Ojeaga A; Alema-Mensah E; Rivers D; Azonobi I; Rivers B
J Cancer Educ; 2019 Feb; 34(1):66-72. PubMed ID: 28808906
[TBL] [Abstract][Full Text] [Related]
39. A reproductive justice approach to understanding women's experiences with HPV and cervical cancer prevention.
Sundstrom B; Smith E; Delay C; Luque JS; Davila C; Feder B; Paddock V; Poudrier J; Pierce JY; Brandt HM
Soc Sci Med; 2019 Jul; 232():289-297. PubMed ID: 31121439
[TBL] [Abstract][Full Text] [Related]
40. Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis.
Choi HCW; Leung K; Chan KKL; Bai Y; Jit M; Wu JT
BMC Med; 2023 Feb; 21(1):48. PubMed ID: 36765349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
